Your browser doesn't support javascript.
loading
MicroRNA-421 confers paclitaxel resistance by binding to the KEAP1 3'UTR and predicts poor survival in non-small cell lung cancer.
Duan, Fu-Gang; Wang, Mei-Fang; Cao, Ya-Bing; Li, Run-Ze; Fan, Xing-Xing; Khan, Imran; Lai, Huan-Ling; Zhang, Yi-Zhong; Hsiao, Wendy Wen-Luan; Yao, Xiao-Jun; Wu, Qi-Biao; Liu, Liang; Tang, Yi-Jun; Leung, Elaine Lai-Han.
Afiliación
  • Duan FG; State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute For Applied Research in Medicine and Health, Macau University of Science and Technology, Macau, SAR, China.
  • Wang MF; Department of Respiratory and Critical Care, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
  • Cao YB; Department of Oncology, Kiang Wu Hospital, Macau, China.
  • Dan Li; Department of Pathology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
  • Li RZ; State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute For Applied Research in Medicine and Health, Macau University of Science and Technology, Macau, SAR, China.
  • Fan XX; State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute For Applied Research in Medicine and Health, Macau University of Science and Technology, Macau, SAR, China.
  • Khan I; State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute For Applied Research in Medicine and Health, Macau University of Science and Technology, Macau, SAR, China.
  • Lai HL; State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute For Applied Research in Medicine and Health, Macau University of Science and Technology, Macau, SAR, China.
  • Zhang YZ; State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute For Applied Research in Medicine and Health, Macau University of Science and Technology, Macau, SAR, China.
  • Hsiao WW; State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute For Applied Research in Medicine and Health, Macau University of Science and Technology, Macau, SAR, China.
  • Yao XJ; State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute For Applied Research in Medicine and Health, Macau University of Science and Technology, Macau, SAR, China.
  • Wu QB; State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute For Applied Research in Medicine and Health, Macau University of Science and Technology, Macau, SAR, China.
  • Liu L; State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute For Applied Research in Medicine and Health, Macau University of Science and Technology, Macau, SAR, China. lliu@must.edu.mo.
  • Tang YJ; Department of Respiratory and Critical Care, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China. tangyijun_799@163.com.
  • Leung EL; State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute For Applied Research in Medicine and Health, Macau University of Science and Technology, Macau, SAR, China. lhleung@must.edu.mo.
Cell Death Dis ; 10(11): 821, 2019 10 28.
Article en En | MEDLINE | ID: mdl-31659154
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Paclitaxel / Carcinoma de Pulmón de Células no Pequeñas / MicroARNs / Proteína 1 Asociada A ECH Tipo Kelch Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cell Death Dis Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Paclitaxel / Carcinoma de Pulmón de Células no Pequeñas / MicroARNs / Proteína 1 Asociada A ECH Tipo Kelch Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cell Death Dis Año: 2019 Tipo del documento: Article